miRview™ mets delivers the results you've been looking for
Unsurpassed accuracy, specificity, and sensitivity
miRview™ mets is a cutting-edge molecular diagnostic test that uses microRNA to identify the tissue-of-origin of metastatic tumors. The test offers unsurpassed accuracy, specificity, and sensitivity.
In the majority of cases, miRview™ mets returns a single tissue prediction with:
- 90% sensitivity1
- 99% specificity1
Sample report
Download Sample Report
- Data on file, Rosetta Genomics.
